Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

On-Target Side Effects of Targeted Therapeutics of Cancer
József Tı́már, Andrea Uhlyarik
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 22

Showing 22 citing articles:

Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
Tatiana Andreani, Ruoyu Cheng, Khalil Elbadri, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2845-2916
Open Access | Times Cited: 22
Nanoparticles in Medicine: Current Status in Cancer Treatment
Krešimir Pavelić, Sandra Kraljević Pavelić, Aleksandar Bulog, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12827-12827
Open Access | Times Cited: 37
Marine algae‐derived characterized bioactive compounds as therapy for cancer: A review on their classification, mechanism of action, and future perspectives
Wei Liao, Yaobin Chen, Shuo Shan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4053-4080
Closed Access | Times Cited: 9
New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis
Xin Li, Jianbo Zhou, Xue Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114806-114806
Open Access | Times Cited: 18
Advances in targeted therapy for pancreatic cancer
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 17
The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases
Marek J. Konieczny, Murad Omarov, Lanyue Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Expression characteristics, immune signatures, and prognostic value of the KIF family members identified across cancers
Xuewei Zhang, Yawei Zhang, Guoxing Zheng, et al.
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Logic-gated approach for targeted delivery and site-selective activation of photothermal agents in precision cancer treatment
Jiang Chang, Zhenxiang Zhao, Amanda K. East, et al.
Chemical Science (2025)
Open Access
Ibuprofen-furo[2,3-d]pyrimidine-based Hybrid Bearing Triazole, Hydrazide and Oxadiazole as Potent Antitumor Agents: Design and Synthesis and Activity Evaluation
Chujie Liao, Chun Feng, Li Li, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139481-139481
Closed Access | Times Cited: 3
Double-Targeted Liposomes Coated with Matrix Metallopeptidase-2-Responsive Polypeptide Nanogel for Chemotherapy and Enhanced Immunotherapy Against Cervical Cancer
Zhimin Bai, Yibo Yang, Zutong Cui, et al.
Materials Today Bio (2024) Vol. 30, pp. 101412-101412
Open Access | Times Cited: 3
Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment
Robert Kleszcz
Cancers (2023) Vol. 15, Iss. 17, pp. 4247-4247
Open Access | Times Cited: 7
The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases
Zhenglin He, Yihan Wang, Liang Han, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Exploration of quinoxaline-benzimidazole hybrids as apoptosis-inducing agents and tubulin polymerisation inhibitors
Ojaswitha Ommi, Shrilekha Chilvery, Priyanka Sudhir Dhopat, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136184-136184
Closed Access | Times Cited: 5
Antibody-drug Conjugates in Cancer Treatment: An Overview
Nikita Gupta, L. Sai Geethika, Payavula Sneha
Journal of Cancer and Tumor International (2024) Vol. 14, Iss. 3, pp. 33-45
Open Access | Times Cited: 1
Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
Guangchun Liu, Shenglin Zhang, Ruoyan Lin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Towards the Application of a Label-Free Approach for Anti-CD47/PD-L1 Bispecific Antibody Discovery
A. S. Grevtsev, Alexandra D. Azarian, Aleksei K. Misorin, et al.
Biosensors (2023) Vol. 13, Iss. 12, pp. 1022-1022
Open Access | Times Cited: 3
The Genomic Architecture of Circulating Cytokine Levels Points to Drug Targets for Immune-Related Diseases
M. Konieczny, Murad Omarov, Rainer Malik, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Obtención y estudio de complejos de coordinación con biometales y ligandos con actividad biológica
Andrés Gonzalo Restrepo Guerrero
(2024)
Open Access
Introduction to the Special Issue Dedicated to Extracellular Vesicles and Nanoparticles, Part 1
Djuro Josić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7805-7805
Open Access
Research progress of novel anti-tumor drug formulations
Yan Liu, Qie Guo, YunYan Shi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium
Nan Ma, Yohanes Cakrapradipta Wibowo, Phillip Wirtz, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 3, pp. 1763-1789
Open Access
PanScreen: A Comprehensive Approach to Off-Target Liability Assessment
Manuel Sellner, Markus A. Lill, Martin Smieško
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top